InvestDashboard.com



Proteon Therapeutics, Inc. (PRTO)



$1.4
52 Week Low
$1.45
2017-04-28 14:17:49 MDT
$11.63
52 Week High

Basic Info

Healthcare
Sector
Biotechnology
Industry
Nasdaq
Stock Exchange
United States
Country

Market Cap: $26,570,000Micro Cap (Less than $200M)
Analyst Recommendation:2.9Analysts say: Neutral. (1=Strong Buy, 5=Strong Sell)
Beta: N/A Unknown Beta. A beta of 1 means that stock will go up or down at the same rate as the S&P 500 index.

Fundamentals

ForwardPE: Unknown
5 Yr Est Growth: Unknown
Yield: 0.00%
PEG-Y Ratio: N/A
Unknown PEG-Y ratio

Technicals

% Above 50 DayMA: -11.59%
% Above 200 DayMA: -67.27%
PRTO Performance 52 Weeks: -84.89%
S&P 500 Performance 52 Weeks: 13.50%
Downtrend is still intact: PRTO is below both 50 and 200 day Moving Averages. Currently beyond technical death cross because 50 Day MA is below 200 Day MA. Stock is closer to 52 Week Low than 52 Week High.
PRTO underperforming S&P 500 by -98.39% the last 52 Weeks.

Profile


More Valuation

Price To Book: 0.71
Great Value. Low Price to Book means better value.
EV to EBITDA: 0.49
Great Value! A low EV to EBITDA ratio is great. Ideally, under 10. Under 17 is okay.

More Info

Field Value Average Comments
% Held By Insiders41.38% 17.28%Held by greater than average Insiders. Insiders can sway stock price. Watch insider buying and selling.
% Held By Institutions54.90% 62.07%Institutional percentage lower than average. Institutions may not have conviction in stock. Or is this a chance for institutions to invest more and boost price?
Short % Of Float2.24% 07.02% Shorted percentage less than average percent. Is stock loved? Do traders and investors believe in the stock?
Debt to EquityN/A 1.08Unknown.
Profit Margin %N/A-00.18%Unknown.
Operating Margin %N/A-05.28%Unknown.
Return on Equity %-56.02%-08.79% Return on Equity less than average percent. Stock can do better than this?
Return on Assets %-32.31%-01.29% Return on Assets less than average percent. Stock can do better than this?
Revenue Per Employee $N/A $883,096.70Unknown.
Price to Cash 0.58 5.52 Lower than average Price to Cash. Meaning that the company has a higher percentage of cash as a percent of price. Cash can be good to cushion company during hard times, and as a potential source for buyouts or investments. However, some activists want the cash to be used by a company to buy its own stock, or to increase their dividend, or to invest the money.
CPEGY Ratio N/A 2.26Unknown.

Quick Thoughts

PROS:
  1. Price to Cash Ratio (0.58) is less than average. Good. Company has more cash as percentage of price than other companies.

  2. Price to Book is under 5: 0.71

  3. Better than average EV/EBITDA: 0.49

  4. Shorted less than average: 2.24%

CONS:
  1. Stock is Below Short Term 50DMA: -11.59%

  2. Stock is Below Long Term 200DMA: -67.27%

  3. Stock underperforming S&P 500 over last 52 weeks: -98.39%

  4. Return on Equity is negative: -56.02%

  5. Return on Assets is negative: -32.31%


Headlines


Stock Chart


InvestDashboard.com PRTO: Proteon Therapeutics, Inc.

This page updated Thu Feb 1 22:00:01 MST 2018.